1-(2-Chloroacetyl)-3-(2,3-dimethylphenyl)urea
1-(2-Chloroacetyl)-3-(2,3-dimethylphenyl) urea is an anticancer agent. 1-(2-Chloroacetyl)-3-(2,3-dimethylphenyl) urea inhibits the growth of colon cancer, cutaneous melanoma and breast cancer. 1-(2-Chloroacetyl)-3-(2,3-dimethylphenyl) urea can be used in the research of colon cancer, cutaneous melanoma and breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 871544-55-7
- Formula: C11H13ClN2O2
- Molecular Weight:240.69
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | GI50 |
6 μM
Compound: 4e
|
Growth inhibition of human HT29 cells after 48 hrs
Growth inhibition of human HT29 cells after 48 hrs
|
[PMID: 17498960] |
| M21 | GI50 |
4.7 μM
Compound: 4e
|
Growth inhibition of human M21 cells after 48 hrs
Growth inhibition of human M21 cells after 48 hrs
|
[PMID: 17498960] |
| MCF7 | GI50 |
6.5 μM
Compound: 4e
|
Growth inhibition of human MCF7 cells after 48 hrs
Growth inhibition of human MCF7 cells after 48 hrs
|
[PMID: 17498960] |
In Vitro
1-(2-Chloroacetyl)-3-(2,3-dimethylphenyl)urea (0.3-10 μM; 48 h) inhibits the growth of HT-29 human colon carcinoma, M21 human skin melanoma, and MCF-7 human breast carcinoma cells with GI50 values in the 1.7 to 10 μM range[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HT-29 human colon carcinoma, M21 human skin melanoma, MCF-7 human breast carcinoma cells
-
Concentration:0.3-10 μM
-
Incubation Time:48 h
-
Result:Exhibited antiproliferative activity with GI50 values between 4.7 and 6.5 μM across the three tumor cell lines.
Chemical Information
-
CAS No. 871544-55-7
-
Molecular Weight 240.69
-
Formula C11H13ClN2O2
-
SMILES
O=C(NC1=CC=CC(C)=C1C)NC(CCl)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)